Nobel Prize laureate Professor Ardem Patapoutian, whose pioneering work revealed how our bodies sense touch and pressure - essential for movement, pain perception, and survival - delivered the 2025 ...

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology can reverse chemotherapy resistance in ...

Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor growth. The technique worked even when only a fraction of tumor cells were ...

CHICAGO, Nov 8 (Reuters) - A single infusion of CRISPR Therapeutics' (CRSP.BN), opens new tab experimental gene therapy was safe and reduced levels of harmful LDL cholesterol and triglycerides by half ...

On Tuesday night, a crowd of professors, Brunswick community members and Bowdoin students filled Mills Hall to attend Professor of Biology Jack Bateman’s inaugural lecture, titled “An Evening of Weird ...

Northwestern scientists have developed a new nanostructure that supercharges CRISPR’s ability to safely and efficiently enter cells, potentially unlocking its full power to treat genetic diseases. By ...

CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on ...

On May 1, the University at Buffalo School of Pharmacy and Pharmaceutical Sciences (UB SPPS) welcomed Michelle Lin, PhD, as our 2025 David Chu Lecturer. The David Chu Lectureship was established in ...

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...

In the world of biopharmaceutical innovation, 2024 will be remembered as CRISPR’s breakout year. In the spring, five patients with sickle cell disease began treatment with Casgevy, the first ...